Your browser doesn't support javascript.
loading
A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Qu, Jingge; Li, Mengtao; Zhang, Xiao; Zhang, Miaojia; Zuo, Xiaoxia; Zhu, Ping; Ye, Shuang; Zhang, Wei; Zheng, Yi; Qi, Wufang; Li, Yang; Zhang, Zhuoli; Ding, Feng; Gu, Jieruo; Liu, Yi; Qian, Junyan; Huang, Can; Zhao, Jiuliang; Wang, Qian; Liu, Yongtai; Tian, Zhuang; Wang, Yanhong; Wei, Wei; Zeng, Xiaofeng.
Affiliation
  • Qu J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatol
  • Li M; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
  • Zhang X; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatol
  • Zhang M; Department of Rheumatology, Guangdong General Hospital, Guangzhou, China.
  • Zuo X; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhu P; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
  • Ye S; Department of Clinical Immunology, PLA Specialized Research Institute of Rheumatology and Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Zhang W; Department of Rheumatology, School of Medicine, Shanghai Jiao Tong University, Ren Ji Hospital South Campus, Shanghai, China.
  • Zheng Y; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Qi W; Department of Rheumatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Li Y; Department of Rheumatology, The First Central Hospital, Tianjin, China.
  • Zhang Z; Department of Rheumatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Ding F; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
  • Gu J; Department of Rheumatology, Qilu Hospital of Shandong University, Jinan, China.
  • Liu Y; Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Qian J; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
  • Huang C; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatol
  • Zhao J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatol
  • Wang Q; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatol
  • Liu Y; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatol
  • Tian Z; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
  • Wang Y; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
  • Wei W; Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zeng X; Department of Rheumatology, Tianjin Medical University General Hospital, No. 154 Anshan Street, Tianjin, 300052, China. tjweiwei2003@163.com.
Respir Res ; 24(1): 220, 2023 Sep 09.
Article in En | MEDLINE | ID: mdl-37689662
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Arterial Hypertension / Hypertension, Pulmonary / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Respir Res Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Arterial Hypertension / Hypertension, Pulmonary / Lupus Erythematosus, Systemic Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Respir Res Year: 2023 Document type: Article Country of publication: